When drugs enter systemic circulation, they interact with various components of the blood, including proteins such as human serum albumin (HSA), α1-acid glycoprotein (AAG), lipoproteins, globulins, and red blood cells (RBCs).

HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are further subdivided into two subgroups per site: IA, IB, IIA, IIB, IIIA, and IIIB. For example, warfarin, certain nonsteroidal anti-inflammatory drugs (NSAIDs), and sodium valproate bind to site I on HSA. Benzodiazepines, ibuprofen, and cloxacillin bind to site II. Diazepam and insulin detemir (Levemir) bind to site III. HSA also contains site IV, which tamoxifen binds to and is known as the tamoxifen binding site. Only a few drugs bind to sites III and IV.

AAG, another plasma protein, binds drugs, including imipramine, lidocaine, and propranolol. This protein can influence the distribution and pharmacokinetics of these drugs within the body.

Lipoproteins transport lipids in the bloodstream and can bind certain lipophilic drugs. Drugs with a high lipid content, such as cyclosporine and amiodarone, exhibit binding to lipoproteins. The extent of this binding can impact the drug's distribution and elimination.

Plasma globulins, including α1-globulin, can bind steroids like cortisone and prednisone. This binding can influence the distribution and pharmacological effects of these drugs.

RBCs also play a role in drug interactions. Lipophilic drugs have a higher affinity for RBCs compared to hydrophilic drugs. Specific components such as hemoglobin, carbonic anhydrase, and cell membranes within RBCs can bind distinct drugs. For example, drugs like phenytoin bind to hemoglobin, while acetazolamide binds to carbonic anhydrase. Imipramine can bind to the RBC membrane.

Understanding these interactions between drugs and blood components is vital in pharmacology. It helps predict drug distribution, metabolism, and pharmacokinetic behavior within the body. Knowledge of these interactions aids in optimizing drug therapy, understanding potential drug-drug interactions, and ensuring effective and safe pharmacological outcomes.

Bölümden 4:

article

Now Playing

4.8 : Drug Binding to Blood Components

Pharmacokinetics: Drug Distribution and Protein Binding

24 Görüntüleme Sayısı

article

4.1 : Drug Distribution: Overview

Pharmacokinetics: Drug Distribution and Protein Binding

65 Görüntüleme Sayısı

article

4.2 : Factors Affecting Drug Distribution: Tissue Permeability

Pharmacokinetics: Drug Distribution and Protein Binding

57 Görüntüleme Sayısı

article

4.3 : Factors Affecting Drug Distribution: Physiological Barriers

Pharmacokinetics: Drug Distribution and Protein Binding

77 Görüntüleme Sayısı

article

4.4 : Factors Affecting Drug Distribution: Organ Perfusion Rate

Pharmacokinetics: Drug Distribution and Protein Binding

34 Görüntüleme Sayısı

article

4.5 : Factors Affecting Drug Distribution: Miscellaneous Factors

Pharmacokinetics: Drug Distribution and Protein Binding

62 Görüntüleme Sayısı

article

4.6 : Volume of Distribution

Pharmacokinetics: Drug Distribution and Protein Binding

41 Görüntüleme Sayısı

article

4.7 : Protein-Drug Binding: Mechanism and Kinetics

Pharmacokinetics: Drug Distribution and Protein Binding

70 Görüntüleme Sayısı

article

4.9 : Tissue-Drug Binding: Localization of Drugs and its Significance

Pharmacokinetics: Drug Distribution and Protein Binding

27 Görüntüleme Sayısı

article

4.10 : Protein-Drug Binding: Determination Methods

Pharmacokinetics: Drug Distribution and Protein Binding

55 Görüntüleme Sayısı

article

4.11 : Factors Affecting Protein-Drug Binding: Drug-Related Factors

Pharmacokinetics: Drug Distribution and Protein Binding

36 Görüntüleme Sayısı

article

4.12 : Factors Affecting Protein-Drug Binding: Protein-Related Factors

Pharmacokinetics: Drug Distribution and Protein Binding

64 Görüntüleme Sayısı

article

4.13 : Factors Affecting Protein-Drug Binding: Drug Interactions

Pharmacokinetics: Drug Distribution and Protein Binding

24 Görüntüleme Sayısı

article

4.14 : Factors Affecting Protein-Drug Binding: Patient-Related Factors

Pharmacokinetics: Drug Distribution and Protein Binding

18 Görüntüleme Sayısı

JoVE Logo

Gizlilik

Kullanım Şartları

İlkeler

Araştırma

Eğitim

JoVE Hakkında

Telif Hakkı © 2020 MyJove Corporation. Tüm hakları saklıdır